Watch Ticker

FibroGen, Inc

Go to FibroGen, Inc Website

$6.74

-0.15 (-2.12%)

Live

Previous Close

$6.89

Day Range

$6.72 - $6.89

Previous Day Range

$6.805 - $7.03

Market Cap

$27.8 million USD

Day Vol.

12342

Previous Day Vol.

14398

Currency

USD

Primary Exchange

Nasdaq

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of no...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million

AstraZeneca has acquired FibroGen's Chinese subsidiary for $160 million, strengthening its position in the Chinese market and enabling FibroGen to focus on its pipeline development in the US.

Related tickers: AZN, FGEN.

Read Full Article

The Brainy Insights - Liver Fibrosis Market Is Expected to Reach USD 43.98 Billion By 2030

The global liver fibrosis market is expected to grow from $17.25 billion in 2021 to $43.98 billion by 2030, driven by the increasing prevalence of liver disorders, adaptation of unhealthy lifestyles, and the rising geriatric population. The North American region dominates the market due to high healthcare expenditure and the presence of major players.

Related tickers: RHHBY, JNJ, SNY, TEVA, PFE, NVS, GSK, MRK, AZN, VRTX, BMY, CELGr, GILD, DVAX, FGEN.

Read Full Article

Trending Tickers

Please sign in to view